Avoro Capital Advisors LLC
CIK 0001633313
Annualised vol
13.898329%
Beta
0.292129
HHI
788.046258
Top-10 weight
79.459154%
VaR 95%
1.192346%
VaR 99%
2.273255%
Max drawdown
28.272886%
Matched value
83.928588%
Holdings (latest quarter)
| Ticker | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | Common | 91307C102 | 1,505,082,912 | 13.52 | 2777777.0 |
| - | ASCENDIS PHARMA | ORDINARY SHARES | K08588103 | 1,363,235,526 | 12.24 | 5111111.0 |
| KRYS | KRYSTAL BIOTECH INC | Common | 501147102 | 1,073,713,003 | 9.64 | 2888888.0 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | 984,408,154 | 8.84 | 1833333.0 |
| ARGX | ARGENX SE | Sponsored ADR | 04016X101 | 927,770,000 | 8.33 | 1000000.0 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | Common | 04280A100 | 925,591,288 | 8.31 | 1.1355555E7 |
| KYMR | KYMERA THERAPEUTICS INC | Common | 501575104 | 857,129,238 | 7.7 | 7474747.0 |
| RVMD | REVOLUTION MEDICINES INC | Common | 76155X100 | 430,182,160 | 3.86 | 2297000.0 |
| CYTK | CYTOKINETICS INC | Common | 23282W605 | 425,949,915 | 3.82 | 4999999.0 |
| CELC | CELCUITY INC | Common | 15102K100 | 355,708,000 | 3.19 | 3400000.0 |
| GPCR | STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 351,836,637 | 3.16 | 6555555.0 |
| XENE | XENON PHARMACEUTICALS INC | Common | 98420N105 | 348,746,620 | 3.13 | 5777777.0 |
| DFTX | DEFINIUM THERAPEUTICS INC | Common | 24477V105 | 338,165,292 | 3.04 | 7188888.0 |
| - | UNIQURE NV | Common | N90064101 | 309,881,409 | 2.78 | 6727777.0 |
| VERA | VERA THERAPEUTICS INC | Common | 92337R101 | 245,612,034 | 2.21 | 5723888.0 |
| TSHA | TAYSHA GENE THERAPIES INC | Common | 877619106 | 162,683,327 | 1.46 | 2.3888888E7 |
| OCUL | OCULAR THERAPEUTIX INC | Common | 67576A100 | 123,142,800 | 1.11 | 1.254E7 |
| DMRA | DAMORA THERAPEUTICS INC | Common | 36322Q206 | 98,395,830 | 0.88 | 3783000.0 |
| - | HEMAB THERAPEUTICS HLDGS INC | Common | 423494103 | 70,710,760 | 0.63 | 1925150.0 |
| GHRS | GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 48,384,000 | 0.43 | 1800000.0 |
| - | VIRIDIAN THERAPEUTICS INC | Common | 92790C104 | 45,925,000 | 0.41 | 2500000.0 |
| SEPN | SEPTERNA INC | Common | 81734D104 | 44,792,875 | 0.4 | 1337500.0 |
| AVTX | AVALO THERAPEUTICS | Common | 05338F306 | 43,119,994 | 0.39 | 2333333.0 |
| FTH | FAETH THERAPEUTICS INC | COMMON | 81728A207 | 36,100,975 | 0.32 | 1444039.0 |
| WHWK | WHITEHAWK THERAPEUTICS INC | Common | 00032Q104 | 13,050,261 | 0.12 | 2849402.0 |
| LXEO | LEXEO THERAPEUTICS INC | Common | 52886X107 | 6,932,175 | 0.06 | 1489189.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | 11,136,250,185 | 26 | 13.898329 | 0.292129 | 28.272886 |
| 2026-03-31 | 2026-05-15 | 10,164,789,055 | 33 | 12.088588 | 0.252767 | 24.746437 |
| 2025-12-31 | 2026-03-16 | 10,174,376,432 | 34 | 11.296969 | 0.233304 | 22.363307 |
| 2025-09-30 | 2025-11-14 | 7,736,501,045 | 32 | 8.91646 | 0.172877 | 16.347987 |
| 2025-03-31 | 2025-05-15 | 6,406,567,714 | 33 | 8.771422 | 0.172783 | 14.793214 |
| 2024-12-31 | 2025-02-14 | 7,069,981,381 | 39 | 10.009687 | 0.215428 | 18.884412 |